Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas

Clinical Endocrinology

Volumn 73, Issue 6, 2010, Pages 815-820

  Jaeschke, Holger ^a   Mueller, Sandra ^a   Eszlinger, Markus ^a   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; INOSITOL PHOSPHATE; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL MUTANT; CELL SURFACE; HUMAN; HUMAN CELL; HYPERTHYROIDISM; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONAUTOIMMUNE HYPERTHYROIDISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; FLOW CYTOMETRY; HUMANS; HYPERTHYROIDISM; MUTAGENESIS, SITE-DIRECTED; MUTATION; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS;

EID: 78649234225     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03872.x     Document Type: Article

References (39)

1. Gozu, H.I., Lublinghoff, J., Bircan, R., et al. (2010) Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Molecular and Cellular Endocrinology, 322, 125 - 34.
2. Kopp, P., (2001) The TSH receptor and its role in thyroid disease. Cellular and Molecular Life Sciences, 58, 1301 - 1322.
3. Duprez, L., Parma, J., Van Sande, J., et al. (1998) TSH receptor mutations and thyroid disease. Trends in Endocrinology and Metabolism, 9, 133 - 140.
4. Parma, J., Duprez, L., VanSande, J., et al. (1994) Constitutively active receptors as a disease-causing mechanism. Molecular and Cellular Endocrinology, 100, 159 - 162.
5. Nogueira, C.R., Kopp, P., Arseven, O.K., et al. (1999) Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid, 9, 1063 - 1068.
6. Sykiotis, G.P., Neumann, S., Georgopoulos, N.A., et al. (2003) Functional significance of the thyrotropin receptor germline polymorphism D727E. Biochemical and Biophysical Research Communications, 301, 1051 - 1056.
7. Sunthornthepvarakul, T., Hayashi, Y., &, Refetoff, S., (1994) Polymorphism of a variant human thyrotropin receptor (hTSHR) gene. Thyroid, 4, 147 - 149.
8. Gozu, H.I., Mueller, S., Bircan, R., et al. (2008) A new silent Germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation. Thyroid, 18, 499 - 508.
9. Mueller, S., Gozu, H.I., Bircan, R., et al. (2009) Cases of borderline in vitro constitutive thyrotropin receptor activity: how to decide whether a thyrotropin receptor mutation is constitutively active or not? Thyroid, 19, 765 - 773.
10. Russo, D., Betterle, C., Arturi, F., et al. (2000) A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH. Journal of Clinical Endocrinology and Metabolism, 85, 4238 - 4242.
11. Kleinau, G., Brehm, M., Wiedemann, U., et al. (2007) Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Molecular Endocrinology, 21, 574 - 580.
12. Fuhrer, D., Tannapfel, A., Sabri, O., et al. (2003) Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocrine-Related Cancer, 10, 591 - 600.
13. Kosugi, S., Shenker, A., &, Mori, T., (1994) Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Letters, 356, 291 - 294.
14. Liu, Z., Sun, Y., Dong, Q., et al. (2008) A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism. Journal of Human Genetics, 53, 475 - 478.
15. Tassi, V., Di Cerbo, A., Porcellini, A., et al. (1999) Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous functioning thyroid nodules in multinodular goiters. Thyroid, 9, 353 - 357.
16. Niepomniszcze, H., Suarez, H., Pitoia, F., et al. (2006) Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid, 16, 497 - 503.
17. Russo, D., Wong, M.G., Costante, G., et al. (1999) A Val 677 activating mutation of the thyrotropin receptor in a Hurthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid, 9, 13 - 17.
18. Jaschke, H., Neumann, S., Moore, S., et al. (2006) A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). Journal of Biological Chemistry, 281, 9841 - 9844.
19. Jaeschke, H., Kleinau, G., Sontheimer, J., et al. (2008) Preferences of transmembrane helices for cooperative amplification of G(alpha)s and G (alpha)q signaling of the thyrotropin receptor. Cellular and Molecular Life Sciences, 65, 4028 - 4038.
20. Mueller, S., Jaeschke, H., &, Paschke, R., (2010) Current standards, variations and pitfalls for the determination of constitutive TSHR activity in vitro. Methods in Enzymology, in press.
21. Porcellini, A., Ciullo, I., Laviola, L., et al. (1994) Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. Journal of Clinical Endocrinology and Metabolism, 79, 657 - 661.
22. Gozu, H.I., Bircan, R., Krohn, K., et al. (2006) Similar prevalence of somatic TSH receptor and Gs alpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. European Journal of Endocrinology, 155, 535 - 545.
23. Trulzsch, B., Krohn, K., Wonerow, P., et al. (2001) Detection of thyroid-stimulating hormone receptor and G(s)alpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. Journal of Molecular Medicine, 78, 684 - 691.
24. Nikiforova, M.N., &, Nikiforov, Y.E., (2009) Molecular diagnostics and predictors in thyroid cancer. Thyroid, 19, 1351 - 1361.
25. Camacho, P., Gordon, D., Chiefari, E., et al. (2000) A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid, 10, 1009 - 1012.
26. Spambalg, D., Sharifi, N., Elisei, R., et al. (1996) Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. Journal of Clinical Endocrinology and Metabolism, 81, 3898 - 3901.
27. Russo, D., Tumino, S., Arturi, F., et al. (1997) Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. Journal of Clinical Endocrinology and Metabolism, 82, 735 - 738. (Pubitemid 27106579)
28. Mircescu, H., Parma, J., Huot, C., et al. (2000) Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. Journal of Pediatrics, 137, 585 - 587.
29. Gozu, H., Avsar, M., Bircan, R., et al. (2004) Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma? Thyroid, 14, 975 - 980.
30. Cetani, F., Tonacchera, M., &, Vassart, G., (1996) Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone chorionic gonadotropin receptors. Febs Letters, 378, 27 - 31.
31. De Roux, N., Polak, M., Couet, J., et al. (1996) A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 81, 2023 - 2026.
32. Claeysen, S., Govaerts, C., Lefort, A., et al. (2002) A conserved Asn in TM7 of the thyrotropin receptor is a common requirement for activation by both mutations and its natural agonist. FEBS Letters, 517, 195 - 200.
33. Parma, J., Van Sande, J., Swillens, S., et al. (1995) Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades. Molecular Endocrinology, 9, 725 - 733.
34. Neumann, S., Claus, M., &, Paschke, R., (2005) Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation. European Journal of Endocrinology, 152, 625 - 634.
35. Ho, S.C., Goh, S.S., Su, Q., et al. (2005) Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity. Molecular and Cellular Endocrinology, 245, 158 - 168.
36. Kosugi, S., Hai, N., Okamoto, H., et al. (2000) A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. European Journal of Endocrinology, 143, 471 - 4777.
37. Urizar, E., Claeysen, S., Deupí, X., et al. (2005) An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. Journal of Biological Chemistry, 280, 17135 - 17141.
38. Paschke, R., Tonacchera, M., Van Sande, J., et al. (1994) Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. Journal of Clinical Endocrinology and Metabolism, 79, 1785 - 1789.
39. Neumann, S., Krause, G., Chey, S., et al. (2001) A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. Molecular Endocrinology, 15, 1294 - 1305.